+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Artificial Intelligence (AI) in Medical Diagnostics Market Size, Share & Industry Trends Analysis Report by Application (In Vivo Diagnostics and In Vitro Diagnostics), End-user, Component (Services and Software), Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 149 Pages
  • October 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5694411
The Europe Artificial Intelligence (AI) in Medical Diagnostics Market should witness market growth of 38.8% CAGR during the forecast period (2022-2028).

The primary application of artificial intelligence in healthcare is to evaluate the link between treatment strategies and patient outcomes. In medical operations such as diagnostic procedures, drug research, tailored medications, and patient monitoring, AI applications are utilized. For instance, AI could assist in clinical procedures by monitoring vital signs, asking patients questions, and providing medicines. During medical procedures, AI systems can also be utilized for alerts and reminders, information retrieval, picture interpretation, and therapeutic planning. Deep learning is the most popular form of AI technology and is used for image identification, signal recognition, and data mining.

Applications of artificial intelligence range from image collecting and processing to assisted reporting, follow-up strategies, data storage, and data mining. The use of machine learning combines computational models and techniques that replicate the architecture of the brain's biological neural network, i.e. artificial neural networks. Performance-wise Traditional machine learning has a lower performance rate than deep learning.

The German healthcare market offers diverse opportunities along the value supply chain route, including Design, research and development collaboration, strategic partnerships, equity partner and investor engagements, mergers and acquisitions, project collaboration, and other opportunities for small and medium-sized enterprises (SMEs) to grow their businesses and expand their market presence. The objective is for faster diagnostics and treatments to help save expenses and provide clients with more timely and accurate care. Furthermore, the integration of AI in healthcare technologies is estimated to be fueled due to this. Hence, this factor would bolster the growth of regional AI in the medical diagnosis market.

The Germany market dominated the Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Country in 2021; thereby, achieving a market value of $490.5 million by 2028. The UK market is exhibiting a CAGR of 37.6% during (2022-2028). Additionally, The France market would experience a CAGR of 39.8% during (2022-2028).

Based on Application, the market is segmented into In Vivo Diagnostics and In Vitro Diagnostics. Based on Vivo Diagnostics Specialty Type, the market is segmented into Radiology, Cardiology, Neurology, Obstetrics/gynecology, Ophthalmology and Others. Based on Vivo Diagnostics Modality Type, the market is segmented into Computed Tomography, X-Ray & Ultrasound, Magnetic Resonance Imaging and Others. Based on End-user, the market is segmented into In Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories and Others. Based on Component, the market is segmented into Services and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Nvidia Corporation, IBM Corporation, Intel Corporation, Google LLC, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Xilinx, Inc., Digital Diagnostics, Inc. and InformAI, LLC

Scope of the Study

By Application

  • In Vivo Diagnostics
    • Vivo Diagnostics Specialty Type
      • Radiology
      • Cardiology
      • Neurology
      • Obstetrics/gynecology
      • Ophthalmology
      • Others
    • Vivo Diagnostics Modality Type
      • Computed Tomography
      • X-Ray & Ultrasound
      • Magnetic Resonance Imaging
      • Others
    • In Vitro Diagnostics

By End-user

  • Hospitals
  • Diagnostics Imaging Centers
  • Diagnostics Laboratories
  • Others

By Component

  • Services
  • Software

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Microsoft Corporation
  • Nvidia Corporation
  • IBM Corporation
  • Intel Corporation
  • Google LLC
  • Siemens Healthineers AG (Siemens AG)
  • General Electric (GE) Co. (GE Healthcare)
  • Xilinx, Inc.
  • Digital Diagnostics, Inc.
  • InformAI, LLC

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Artificial Intelligence (AI) in Medical Diagnostics Market, by Application
1.4.2 Europe Artificial Intelligence (AI) in Medical Diagnostics Market, by End-user
1.4.3 Europe Artificial Intelligence (AI) in Medical Diagnostics Market, by Component
1.4.4 Europe Artificial Intelligence (AI) in Medical Diagnostics Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, Nov - 2022, Oct) Leading Players
Chapter 4. Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Application
4.1 Europe In Vivo Diagnostics Market by Country
4.2 Europe Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
4.2.1 Europe Radiology Market by Country
4.2.2 Europe Cardiology Market by Country
4.2.3 Europe Neurology Market by Country
4.2.4 Europe Obstetrics/gynecology Market by Country
4.2.5 Europe Ophthalmology Market by Country
4.2.6 Europe Others Market by Country
4.3 Europe Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
4.3.1 Europe Computed Tomography Market by Country
4.3.2 Europe X-Ray & Ultrasound Market by Country
4.3.3 Europe Magnetic Resonance Imaging Market by Country
4.3.4 Europe Others Market by Country
4.4 Europe In Vitro Diagnostics Market by Country
Chapter 5. Europe Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
5.1 Europe Hospitals Market by Country
5.2 Europe Diagnostics Imaging Centers Market by Country
5.3 Europe Diagnostics Laboratories Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Component
6.1 Europe Services Market by Country
6.2 Europe Software Market by Country
Chapter 7. Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Country
7.1 Germany Artificial Intelligence (AI) in Medical Diagnostics Market
7.1.1 Germany Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.1.1.1 Germany Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.1.1.2 Germany Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.1.2 Germany Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.1.3 Germany Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.2 UK Artificial Intelligence (AI) in Medical Diagnostics Market
7.2.1 UK Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.2.1.1 UK Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.2.1.2 UK Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.2.2 UK Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.2.3 UK Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.3 France Artificial Intelligence (AI) in Medical Diagnostics Market
7.3.1 France Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.3.1.1 France Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.3.1.2 France Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.3.2 France Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.3.3 France Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.4 Russia Artificial Intelligence (AI) in Medical Diagnostics Market
7.4.1 Russia Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.4.1.1 Russia Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.4.1.2 Russia Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.4.2 Russia Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.4.3 Russia Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.5 Spain Artificial Intelligence (AI) in Medical Diagnostics Market
7.5.1 Spain Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.5.1.1 Spain Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.5.1.2 Spain Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.5.2 Spain Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.5.3 Spain Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.6 Italy Artificial Intelligence (AI) in Medical Diagnostics Market
7.6.1 Italy Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.6.1.1 Italy Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.6.1.2 Italy Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.6.2 Italy Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.6.3 Italy Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.7 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market
7.7.1 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.7.1.1 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.7.1.2 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.7.2 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market by End-user
7.7.3 Rest of Europe Artificial Intelligence (AI) in Medical Diagnostics Market by Component
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent Strategies and Developments
8.1.5.1 Partnerships, Collaborations, and Agreements
8.1.5.2 Product Launches and Product Expansions
8.1.5.3 Acquisition and Mergers
8.1.6 SWOT Analysis
8.2 NVIDIA Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Product Launches and Product Expansions
8.2.6 SWOT Analysis
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and Developments
8.3.5.1 Partnerships, Collaborations, and Agreements
8.3.5.2 Product Launches and Product Expansions
8.3.6 SWOT Analysis
8.4 Intel Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent Strategies and Developments
8.4.5.1 Product Launches and Product Expansions
8.4.6 SWOT Analysis
8.5 Google LLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent Strategies and Developments
8.5.5.1 Partnerships, Collaborations, and Agreements
8.5.5.2 Product Launches and Product Expansions
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent Strategies and Developments
8.6.5.1 Partnerships, Collaborations, and Agreements
8.6.5.2 Product Launches and Product Expansions
8.6.5.3 Acquisition and Mergers
8.6.5.4 Approvals and Trials
8.6.6 SWOT Analysis
8.7 General Electric (GE) Co. (GE Healthcare)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and Developments
8.7.5.1 Partnerships, Collaborations, and Agreements
8.7.5.2 Product Launches and Product Expansions
8.7.6 SWOT Analysis
8.8 Xilinx, Inc. (Advanced Micro Devices, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent Strategies and Developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.8.5.2 Acquisition and Mergers
8.9 Digital Diagnostics, Inc.
8.9.1 Company Overview
8.9.2 Recent Strategies and Developments
8.9.2.1 Partnerships, Collaborations, and Agreements
8.9.2.2 Acquisition and Mergers
8.10. InformAI, LLC
8.10.1 Company Overview

Companies Mentioned

  • Microsoft Corporation
  • Nvidia Corporation
  • IBM Corporation
  • Intel Corporation
  • Google LLC
  • Siemens Healthineers AG (Siemens AG)
  • General Electric (GE) Co. (GE Healthcare)
  • Xilinx, Inc.
  • Digital Diagnostics, Inc.
  • InformAI, LLC

Methodology

Loading
LOADING...